Zohra Oum'Hamed

In vitro reactions of human osteoblasts in culture with zirconia and alumina ceramics

Y. Josset, Zohra Oum'Hamed, A. Zarrinpour et al. · Journal of Biomedical Materials Research · 1999 · 158 citations

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

Eric Van Cutsem, Takayuki Yoshino, Heinz‐Josef Lenz et al. · Annals of Oncology · 2018 · 63 citations · Full text

First-in-human dose-escalation trial of BI 764532, a delta-like ligand 3 (DLL3)/CD3 IgG-like T-cell engager in patients (pts) with DLL3-positive (DLL3+) small-cell lung cancer (SCLC) and neuroendocrine carcinoma (NEC).

Martin Wermke, Enriqueta Felip, Yasutoshi Kuboki et al. · Journal of Clinical Oncology · 2023 · 47 citations

Immunology, Dll3+ Cells, Inhibitory Notch Ligand +19

A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients

Eric Van Cutsem, Hans Prenen, Geert D’Haens et al. · Annals of Oncology · 2015 · 40 citations · Full text

Oncology, Medicine, Colorectal Cancer +6

Matrix metalloproteinases MMP‐2, ‐9 and tissue inhibitors TIMP‐1, ‐2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics

Zohra Oum'Hamed, Roselyne Garnotel, Y. Josset et al. · Journal of Biomedical Materials Research Part A · 2003 · 29 citations · Full text